Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: A randomised controlled trial

Lancet

Volumn 356, Issue 9240, 2000, Pages 1480-1485

  Brightling, Christopher E ^a   Monteiro, William ^a   Ward, Richard ^a   Parker, Debbie ^a   Morgan, Michael D L ^a   Wardlaw, Andrew J ^a   Pavord, Ian D ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; PLACEBO; PREDNISOLONE;

AGED; ARTICLE; CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EOSINOPHILIA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SCHOOL CHILD; SCORING SYSTEM; SPIROMETRY; SPUTUM ANALYSIS;

EID: 0034727453     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02872-5     Document Type: Article

References (29)

1. Glucocorticoid therapy for chronic obstructive pulmonary disease
2. Guidelines for the management of chronic obstructive pulmonary disease
3. Re-assessing the evidence about inhaled corticosteroids in chronic obstructive pulmonary disease
4. Non-eosinophilic corticosteroid unresponsive asthma
5. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD
6. Response to corticosteroids in chronic bronchitis
7. Steroid therapy in chronic bronchitis
8. Indices of airway inflammation in induced sputum: Reproducibility and validity of celt and fluid phase measurements
9. The safety and success rate of sputum induction using a low output ultrasonic nebuliser
10. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis
11. Corticosteroid trials in non-asthmatic chronic airflow obstruction: A comparison of oral prednisolone and inhaled beclomethasone dipropionate
12. A measure of quality of life for clinical trials in chronic lung disease
13. The development of the shuttle walking test of disability in patients with chronic airways obstruction
14. The use of induced sputum to investigate airway inflammation
15. Levels of elastase activity in bronchoalveolar lavage fluids of healthy smokers and nonsmokers
16. Short term variability in FEV, and bronchodilator responsiveness in patients with obstructive ventilatory defects
17. Corticosteroid reversibility in COPD is related to features of asthma
18. Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease
19. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma
20. Severity of airflow limitation is associated with severity of airway inflammation in smokers
21. 1 in smokers are associated with increased levels of sputum neutrophils
22. Airway eosinophilia in chronic bronchitis during exacerbations
23. Inhaled steroids in COPD
24. Eosinophilic airway inflammation induced by repeated exposure to cigarette smoke
25. Eosinophilic bronchitis is an important cause of cough
26. The development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma
27. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
28. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking
29. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease; a randomised controlled trial